International Clinical Trial: Melatonin Administration for Alleviating Clinical Symptoms of Burning Mouth Syndrome: An Open-Label, Randomised Controlled Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115337) titled 'Melatonin Administration for Alleviating Clinical Symptoms of Burning Mouth Syndrome: An Open-Label, Randomised Controlled Trial' on Dec. 24, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: West China School/Hospital of Stomatology, Sichuan University

Condition: Burning mouth syndrome

Intervention: Melatonin + alpha-lipoic acid (ALA) group:Take alpha-lipoic acid (ALA), which is currently commonly used to treat BMS, three times a day, 200mg each time, for four consecutive weeks. And take melatonin. The patient takes 2.24mg of melatonin 0.5 to 1 hour before going to bed every ...